| The prevalence of MS in the United States: a population-based estimate using health claims data MT Wallin, WJ Culpepper, JD Campbell, LM Nelson, A Langer-Gould, ... Neurology 92 (10), e1029-e1040, 2019 | 953 | 2019 |
| Blood eosinophil count and prospective annual asthma disease burden: a UK cohort study DB Price, A Rigazio, JD Campbell, ER Bleecker, CJ Corrigan, M Thomas, ... The lancet Respiratory medicine 3 (11), 849-858, 2015 | 549 | 2015 |
| Multiple sclerosis prevalence in the United States commercially insured population P Dilokthornsakul, RJ Valuck, KV Nair, JR Corboy, RR Allen, ... Neurology 86 (11), 1014-1021, 2016 | 305 | 2016 |
| Computed tomography correlates with pulmonary exacerbations in children with cystic fibrosis AS Brody, H Sucharew, JD Campbell, SP Millard, PL Molina, JS Klein, ... American journal of respiratory and critical care medicine 172 (9), 1128-1132, 2005 | 170 | 2005 |
| The costs of treating breast cancer in the US: a synthesis of published evidence JD Campbell, SD Ramsey Pharmacoeconomics 27, 199-209, 2009 | 169 | 2009 |
| Societal implications of health insurance coverage for medically necessary services in the US transgender population: a cost-effectiveness analysis WV Padula, S Heru, JD Campbell Journal of general internal medicine 31, 394-401, 2016 | 156 | 2016 |
| Burden of multiple sclerosis on direct, indirect costs and quality of life: National US estimates JD Campbell, V Ghushchyan, RB McQueen, S Cahoon-Metzger, ... Multiple sclerosis and related disorders 3 (2), 227-236, 2014 | 153 | 2014 |
| Community health worker home visits for Medicaid-enrolled children with asthma: effects on asthma outcomes and costs JD Campbell, M Brooks, P Hosokawa, J Robinson, L Song, J Krieger American Journal of Public Health 105 (11), 2366-2372, 2015 | 150 | 2015 |
| Comparison of weighting methods used in multicriteria decision analysis frameworks in healthcare with focus on low-and middle-income countries B Németh, A Molnár, S Bozóki, K Wijaya, A Inotai, JD Campbell, Z Kaló Journal of comparative effectiveness research 8 (4), 195-204, 2019 | 145 | 2019 |
| US Multiple Sclerosis Prevalence Workgroup. The prevalence of MS in the United States: a population-based estimate using health claims data MT Wallin, WJ Culpepper, JD Campbell, LM Nelson, A Langer-Gould, ... Neurology 92 (10), e1029-e1040, 2019 | 119 | 2019 |
| Asthma outcomes: healthcare utilization and costs LJ Akinbami, SD Sullivan, JD Campbell, RW Grundmeier, TV Hartert, ... Journal of Allergy and Clinical Immunology 129 (3), S49-S64, 2012 | 111 | 2012 |
| The costs and consequences of omalizumab in uncontrolled asthma from a USA payer perspective JD Campbell, DE Spackman, SD Sullivan Allergy 65 (9), 1141-1148, 2010 | 99 | 2010 |
| Cost-effectiveness of intra-arterial treatment as an adjunct to intravenous tissue-type plasminogen activator for acute ischemic stroke MH Leppert, JD Campbell, JR Simpson, JF Burke Stroke 46 (7), 1870-1876, 2015 | 98 | 2015 |
| Long-term survival and cost-effectiveness associated with axicabtagene ciloleucel vs chemotherapy for treatment of B-cell lymphoma MD Whittington, RB McQueen, DA Ollendorf, VM Kumar, RH Chapman, ... JAMA network open 2 (2), e190035-e190035, 2019 | 92 | 2019 |
| Comparison of anticancer drug coverage decisions in the United States and United Kingdom: does the evidence support the rhetoric? A Mason, M Drummond, S Ramsey, J Campbell, D Raisch Journal of Clinical Oncology 28 (20), 3234-3238, 2010 | 90 | 2010 |
| Cost-effectiveness of biological asthma treatments: a systematic review and recommendations for future economic evaluations RB McQueen, DN Sheehan, MD Whittington, JFM van Boven, ... Pharmacoeconomics 36, 957-971, 2018 | 88 | 2018 |
| The promise of Immuno-oncology: implications for defining the value of cancer treatment HL Kaufman, MB Atkins, P Subedi, J Wu, J Chambers, T Joseph Mattingly, ... Journal for immunotherapy of cancer 7, 1-11, 2019 | 87 | 2019 |
| Long-term survival and value of chimeric antigen receptor T-cell therapy for pediatric patients with relapsed or refractory leukemia MD Whittington, RB McQueen, DA Ollendorf, VM Kumar, RH Chapman, ... JAMA pediatrics 172 (12), 1161-1168, 2018 | 87 | 2018 |
| Disease-specific reference equations for lung function in patients with cystic fibrosis M Kulich, M Rosenfeld, J Campbell, R Kronmal, RL Gibson, CH Goss, ... American journal of respiratory and critical care medicine 172 (7), 885-891, 2005 | 84 | 2005 |
| Assessing the value of mepolizumab for severe eosinophilic asthma: a cost-effectiveness analysis MD Whittington, RB McQueen, DA Ollendorf, JA Tice, RH Chapman, ... Annals of Allergy, Asthma & Immunology 118 (2), 220-225, 2017 | 83 | 2017 |
R. Brett McQueenUniversity of Colorado Skaggs School of Pharmacy and Pharmaceutical SciencesVerified email at ucdenver.edu
